Defective MPDU1 causes CDG-1f

Stable Identifier
R-HSA-4687000
Type
Pathway
Species
Homo sapiens
Synonyms
Defective MPDU1 causes MPDU1-CDG
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Defective MPDU1 causes CDG-1f
Click the image above or here to open this pathway in the Pathway Browser
Mannose-P-dolichol utilisation defect 1 protein (MPDU1) is required for the efficient utilisation of the mannose donor dolichyl-phospho-mannose (DOLPman) in the synthesis of both lipid-linked oligosaccharides (LLOs) and glycosylphosphatidylinositols. Defects in MPDU1 can cause congenital disorder of glycosylation 1f (MPDU1-CDG, CDG-1f; MIM:609180), a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterised by under-glycosylated serum glycoproteins. CDG type 1 diseases result in a wide phenotypic spectrum, such as poor neurological development, psychomotor retardation, dysmorphic features, hypotonia, coagulation abnormalities and immunodeficiency. In this condition, DOLPman is no longer utilised in transferase reactions extending LLOs, even as substrate levels and transferase enzyme activities appear normal (Anand et al. 2001, Schenk et al. 2001).
Literature References
PubMed ID Title Journal Year
11733564 MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If

Frank, CG, Revel-Vik, S, Raymond, GV, Hurvitz, H, Imbach, T, Aebi, M, Matthijs, G, Schenk, B, Berger, EG, Raas-Rotschild, A, Grubenmann, CE, Hennet, T, Luder, AS, Korn-Lubetzki, I, Jaeken, J

J. Clin. Invest. 2001
11179430 Requirement of the Lec35 gene for all known classes of monosaccharide-P-dolichol-dependent glycosyltransferase reactions in mammals

Ware, FE, Lehrman, MA, Hofsteenge, J, Doucey, MA, Weik, J, Ray, S, Rush, JS, Waechter, CJ, Anand, M

Mol. Biol. Cell 2001
Participants
Events
Participates
as an event of
Disease
Authored
Jassal, B  (2013-10-15)
Reviewed
Belaya, K  (2014-10-31)
Created
Jassal, B  (2013-10-15)
Cite Us!